Acne Medicine 'Accutane' Causing Birth Defects, Depression, Suicides
Accutane, a medicine for acne, is causing birth defects, depression and suicides, allege researchers. Dr. David Graham, associate director of the FDA's office of drug safety, named Accutane as one of the drugs he says should be restricted or withdrawn from the market, according to this article in the Washington Post. In a Tampa, Florida legal case against Hoffmann LaRoche, a host of documents on Accutane's effects has been produced by the drug maker. Unfortunately, federal judge James Moody ruled that documents filed in the case could not be "passed on" to others who have similar legal cases pending.
The drug has caused scores of birth defects, which are acknowledged by the company in its product information. According to a report of Vera Hassner Sharav of the Alliance for Human Research Protection, the FDA in 2002 had knowledge of 173 suicide reports associated with Accutane. The manufacturer says the drug is safe.
Hold on a minute. An acne drug associated with deadly side effects? Acne is by no means a life-threatening condition. Babies being born deformed for life, hundreds, and possibly thousands of young people committing suicide? What could induce our health authorities to allow deadly drugs such as Accutane on the market, when on the other side they are campaigning to limit the availability of vitamins, minerals and other nutrients?
Money? Double standard? I haven't been able to make sense of this...
- - -
ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP)
Promoting Openness, Full Disclosure, and Accountability
www.ahrp.org
Judge James Moody, A federal judge in Tampa, Florida, ruled against plaintiff lawyers who sought to share internal documents belonging to Hoffman-LaRoche that show the company knew about the increased suicide risk associated with the acne drug, Accutane.The company’s own safety experts had recommended in 1997 changing the US label to reflect the evidence that Accutaine “probably caused” depression and other psychiatric illnesses in some patients.” USA Today reported (December 7, 2004) that Hoffman’s head of regulatory affairs testified in court that the marketing division argued that such a warning would “impact on marketing strategy and product liability.” The marketing division prevailed and no such warning was issued. (see: http://www.ahrp.org/infomail/04/12/07.php)
Accutane is one of five drugs that FDA’s senior safety officer, Dr. David Graham, named in his Senate testimony as a possible candidate for withdrawal from marketing.
USA Today published a chronology of Accutane findings:
For example, in 1999, Roche told the FDA that none of the 168 reports of suicidal behavior can be directly linked to Accutane.In 2000, during an FDA dermatology committee meeting, the agency confirmed that 147 suicides were linked to patients taking Accutane.
In 2002, Janet Woodcock, director of FDA's Center for Drug Evaluation and Research, told a congressional committee that the agency had received reports of 3,104 adverse psychiatric events involving Accutane and that the FDA knew of 173 suicide reports associated with Accutane.
Furthermore, USA Today reported that in 1988, Godfrey Oakley, director of the Division of Birth Defects and Developmental Disabilities at the Centers for Disease Control, wrote that "40 infants born alive after first trimester exposure to Accutane have died ... because of the developmental errors that Accutane caused." Oakley argued that "we simply need to remove the drug from the market."
In 2004, The Alliance for Human Research Protection asked Keith Altman, Adverse Drug Reaction Statistics Analyst, to analyze FDA's Medwatch database for drug-linked suicides by children under 18 years of age.
He found that between 1989 and June 2003, there were 216 reported drug-linked suicides in under 18 year olds. Of these, 72 suicides were linked to Accutane. The next highest number of suicides - 55—involved Prozac.
Since MedWatch reflects approximately 1% of actual adverse drug events, 72 Accutane suicide reports represent 7,200 suicides. And 55 Prozac-related suicide reports represent 5,500 suicides.
The judge indicated that attorneys could ask the court to open up records if they discover a matter of public safety as they prepare their cases. One wonders what standard the judge uses to determine when a drug hazard is “a matter of public safety?”
One also wonders why the FDA had failed to require disclosure to physicians that Accutane posed an increased suicide risk?
Contact: Vera Hassner Sharav
212-595-8974
veracare@ahrp.org
Acne Drug Memos Kept Secret Despite SuitsJanuary 28, 2005 8:49 PM EST
TAMPA, Fla. - Lawyers suing the makers of Accutane over allegations the acne drug increases the risk of suicide cannot share the company's internal memos and other documents with the public or federal regulators, a judge ruled Friday.
The attorneys had sought to make public as many as 1 million documents produced by Hoffman-La Roche Inc., saying the disclosure was needed as Accutane's safety comes under increased scrutiny by the U.S. Food and Drug Administration.
U.S. District Judge James Moody rejected the request, saying attorneys could ask the court to open up records if they discover a matter of public safety as they prepare their cases. But in a victory for the plaintiffs, he said the drug maker cannot redact documents before handing them over to the attorneys.
Moody, based in Tampa, is presiding over the management of dozens of lawsuits filed nationwide over Accutane, used by about 5 million Americans.
The drug, which has been dispensed in the United States since 1982, has been blamed for increased rates of suicide and gastrointestinal diseases in some users and birth defects in babies born to mothers who took Accutane.
Hoffman-La Roche contends the drug is safe, although it recommends that users be screened for depression. The company notes that teenagers and young adults, the groups most likely to use the drug, have higher suicide rates than the general population.
The documents at issue include internal company discussions about the safety of the drug and how to handle allegations of an increased suicide risk.
Hoffman-La Roche attorney Ed Moss said the company fought the release of the documents mostly out of concern for protecting Accutane's "recipe," and that federal officials already have internal documents relating to the drug's safety.
"We are not trying to hide documents from the public," Moss said. "We have given everything in the world to the FDA."
FDA scientist David Graham testified before Congress last year that Accutane was one of five dangerous drugs that should be restricted or removed from the market. In November, federal regulators toughened rules on Accutane, requiring doctors and pharmacists who dispense the drug to register patients on a central database.
Among the Accutane cases is a $70 million lawsuit brought by the mother and grandmother of Charles Bishop, the 15-year-old who stole a small airplane and crashed into a Tampa high rise in January 2002. His family blames his use of the drug for bringing on the dramatic suicide, but the company contends that he was a troubled young man and it is not to blame.
Hoffman-La Roche Inc., based in Nutley, N.J., is the United States prescription drug unit of the Swiss drug maker Roche Group.
See also:
Roche puts Accutane profits over Lives of Consumers
In 1985, Accutane's package insert directed at doctors first mentioned reports of depression in patients taking the acne drug, which means that more than 20 years ago, Hoffman-LaRoche at least suspected there might be a risk of depression and suicide by persons taking the drug.However, Roche's financial records show that the company is not about to let a little thing like the death of its customers get in the way of corporate profits, because the drug is still a best seller and young people with no history of depression who take it are still killing themselves.
One Man's Quest to Uncover the Toxic Secrets Behind Accutane
FDA puts stricter controls on acne drug
By Ricardo Alonso-Zaldivar - Los Angeles Times
WASHINGTON — Federal regulators yesterday unveiled a high-tech system to restrict distribution of Accutane, an acne drug taken by thousands of Americans. The drug has been particularly effective against severe acne, but has long been known to cause birth defects and is now being studied for a possible connection to teenage suicides.22 August 2005: FDA poses stricter regulations for the acne drug Accutane
It is hoped that birth defects and miscarriages associated with the skin care drug Accutane will decrease under tight new laws from the FDA.Family blame acne drug for death
From BBC News - 20 September 2005: The family of a student who hanged himself have blamed a drug he was taking to treat acne. David Roberts, 21, had been taking Roaccutane for two months when he hanged himself near his Liverpool home. Coroner Andre Rebello recorded a narrative verdict and said there was not enough evidence to link the death with the drug. Roaccutane's manufacturer Roche insists there is no proven relationship between the drug and depression. However, Mr Roberts' father, Fred Roberts, said he could think of no other explanation for the tragedy.Accutane - Another Case of Too Little Too Late
Accutane is prescribed to treat a type of severe acne called nodular acne which causes red, swollen, tender lumps to form under the skin. Accutane is supposed to be used only when all other treatments, including antibiotics, have failed. The treatment usually lasts 4 or 5 months, at a cost of about $3000, including lab tests and doctor's visits. The drug is manufactured by Roche Pharmaceuticals and is also marketed under the generic names Amnesteem, Claravis, Isotretinoin, and Sotret. The FDA estimates that about 100,000 prescriptions for the drug are written in the US each month. Accutane has many side effects. Patients have been known to develop serious mental health problems and the FDA has acknowledged reports of suicide or suicide attempts associated with use of the drug...Accutane linked to heart, liver risk
Accutane, the powerful acne drug already known to cause birth defects, seems to raise the risk for potential heart and liver problems more than doctors had expected, according to a new study.
The findings came from lab tests on 13,772 patients taking the popular acne drug and underscore the need to closely monitor people taking isotretinoin, which is sold as Accutane. Abnormal results for cholesterol and liver function were more common than expected.Research shows link between acne treatment and depression
The first scientific evidence of a link between a drug for severe acne and depression was unveiled yesterday, following years of denials by the manufacturer that the prescription medicine could be in any way responsible for suicides. Roaccutane has been linked to more than 100 suicides and attempted suicides worldwide.Acne drug 'linked to depression and suicide'
The new study suggests the drug may disrupt serotonin production in the brain, leading to feelings of despair. Roaccutane (Acutane in the US) has been linked with at least 15 deaths in the UK and more than 200 in the United States, and bereaved parents have previously called for the drug to be taken out of use.
posted by Sepp Hasslberger on Monday January 31 2005
updated on Friday November 16 2007URL of this article:
http://www.newmediaexplorer.org/sepp/2005/01/31/acne_medicine_accutane_causing_birth_defects_depression_suicides.htm
Related ArticlesFDA Misses Risky Business
The FDA is charged with controlling the safety and efficacy of drugs before marketing, but judging from available statistics, pharmaceutical drugs have become more of a problem than a help in achieving good health. John Hammell, president of the International Advocates For Health Freedom contends the FDA is not able to independently evaluate possible dangers of new pharmaceuticals to be approved. Researchers of the agency are often pressured into changing... [read more]
November 15, 2003 - Sepp HasslbergerIn the FDA we trust?
..."Last Daily Dose, I spilled a story that many in the medical mainstream (and the drug companies they're slaves to) would no doubt love to keep under wraps: A possible link between antidepressant drugs and suicide in depressed juveniles. But the ironic part of the story was that the red flag on this potential link is being hoisted not by a marquis medical journal, some big-name investigative reporter, or even... [read more]
January 03, 2004 - Chris GuptaFDA Covers Up Report - Mosholder: 'Antidepressants Double Suicides in Children'
According to a recent article published in the British Medical Journal, a scientific report by one of its researchers, Dr. Andrew Mosholder, showing that antidepressant drugs double the suicide rate in children taking them, was suppressed by the FDA. Instead of owning up to its mistake and issuing generalized warnings, the agency has launched a criminal investigation to find out which employees leaked Dr. Mosholder's report. Apart from the FDA's... [read more]
August 12, 2004 - Sepp HasslbergerFDA Waffles Over Antidepressants Causing Suicides
According to an article in the New York Times, officials of the FDA are now acknowledging that antidepressants do cause children and teenagers to become suicidal, but the FDA is not taking the steps it should - ban the drugs for use in children, as the UK has already done. The major preoccupation seems to be that if antidepressants are removed or carry strong warnings, there is nothing left to... [read more]
September 15, 2004 - Sepp HasslbergerEli Lilly Knew Prozac Causes Suicides, Violence - FDA Closed Both Eyes
Prozac, called fluoxetine by generic name, is a psychiatric drug prescribed to over 50 million people including millions of children. The drug was linked to increased suicides and violence as early as 1988, in a recently emerged document. Apparently the evaluation was known to Prozac's maker Eli Lilly as early as the 'eighties, but was never even given to the FDA. This is the preoccupying picture that emerged just days... [read more]
January 01, 2005 - Sepp HasslbergerVioxx Shows: FDA Unable To Protect Public From Deadly Medical Drugs
According to recent congressional testimony, "the FDA as currently configured is incapable of protecting America against another Vioxx. We are virtually defenceless," said David Graham, associate director of the agency's Office of Drug Safety. The quote is from an article published in South Africa, titled Doctor: FDA is too cosy with drug firms. The FDA is the national food and medicines regulatory agency of the US but it has been... [read more]
November 23, 2004 - Sepp Hasslberger
